Home Compare AFX.DE vs AMP.MI
Stock Comparison · Cheaper and stronger

Carl Zeiss Meditec vs Amplifon S.p.A.: Which Stock Looks Stronger in 2026?

Carl Zeiss Meditec holds the cleaner structural position, with valuation as the main driver and growth adding further support. Amplifon S.p.A does not offset that deficit through any equally strong structural edge elsewhere. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

This is not just a one-metric split: both valuation and growth materially support the lead. The overall score gap is 23 points in favour of Carl Zeiss Meditec AG.

Trajectory Similarity
0.69
Moderately similar
Peer-set rank: #11
within Carl Zeiss Meditec AG's functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

The strongest overlap appears in capital structure and revenue stability.

Similarity drivers
capital structurerevenue stability
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
AFX.DE
Carl Zeiss Meditec AG
47
Peer-Score
Signal qualityHigh
vs
AMP.MI
Amplifon S.p.A.
24
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Pricing and operating quality both support the lead here.

Dimension spread: AFX.DE vs AMP.MI Profitability 35 14 Stability 24 9 Valuation 86 57 Growth 28 5 AFX.DE AMP.MI
Gap Ranking
#1 Valuation +29
#2 Growth +23
#3 Profitability +21
#4 Stability +15
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for AFX.DE and AMP.MI Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer AFX.DEAMP.MI Relative valuation Structural strength

Carl Zeiss Meditec AG looks stronger both structurally and on relative valuation.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Valuation
Both profiles are strong on valuation, but Carl Zeiss Meditec AG leads clearly.
Growth
Neither side looks especially strong on growth, though Carl Zeiss Meditec AG still ranks somewhat higher.
Valuation — Dominant Gap
AFX.DE
86
AMP.MI
57
Gap+29in favour of AFX.DE

The multiple-based pricing edge comes from a trailing P/E that is 7.7 turns lower.

What else supports the lead

Earnings growth is one contributing factor within the growth lead.

What this means for the comparison

Valuation is the clearest driver, and growth also supports Carl Zeiss Meditec AG's broader structural position.

Explore full peer positioning in AssetNext

Break down the AFX.DE vs AMP.MI comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar valuation-and-growth comparisons

Explore how AFX.DE and AMP.MI each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.